These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23764641)

  • 1. Cross-sectional HIV incidence estimation in HIV prevention research.
    Brookmeyer R; Laeyendecker O; Donnell D; Eshleman SH
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S233-9. PubMed ID: 23764641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of HIV incidence using multiple biomarkers.
    Brookmeyer R; Konikoff J; Laeyendecker O; Eshleman SH
    Am J Epidemiol; 2013 Feb; 177(3):264-72. PubMed ID: 23302151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.
    Konikoff J; Brookmeyer R; Longosz AF; Cousins MM; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Koblin BA; Justman JE; Hodder SL; Quinn TC; Eshleman SH; Laeyendecker O
    PLoS One; 2013; 8(12):e82772. PubMed ID: 24386116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.
    Cousins MM; Konikoff J; Sabin D; Khaki L; Longosz AF; Laeyendecker O; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Kobin BA; Wheeler D; Justman JE; Hodder SL; Quinn TC; Brookmeyer R; Eshleman SH
    PLoS One; 2014; 9(6):e101043. PubMed ID: 24968135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART).
    Grant-McAuley W; Klock E; Laeyendecker O; Piwowar-Manning E; Wilson E; Clarke W; Breaud A; Moore A; Ayles H; Kosloff B; Shanaube K; Bock P; Mandla N; van Deventer A; Fidler S; Donnell D; Hayes R; Eshleman SH;
    PLoS One; 2021; 16(12):e0258644. PubMed ID: 34919554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.
    Cousins MM; Konikoff J; Laeyendecker O; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Koblin BA; Wheeler D; Justman JE; Hodder SL; Quinn TC; Brookmeyer R; Eshleman SH
    J Clin Microbiol; 2014 Jan; 52(1):115-21. PubMed ID: 24153134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.
    Moyo S; LeCuyer T; Wang R; Gaseitsiwe S; Weng J; Musonda R; Bussmann H; Mine M; Engelbrecht S; Makhema J; Marlink R; Baum MK; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):29-36. PubMed ID: 23937344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment.
    Grant-McAuley W; Laeyendecker O; Monaco D; Chen A; Hudelson SE; Klock E; Brookmeyer R; Morrison D; Piwowar-Manning E; Morrison CS; Hayes R; Ayles H; Bock P; Kosloff B; Shanaube K; Mandla N; van Deventer A; Ruczinski I; Kammers K; Larman HB; Eshleman SH
    BMC Infect Dis; 2022 Nov; 22(1):838. PubMed ID: 36368950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV incidence determination in the United States: a multiassay approach.
    Laeyendecker O; Brookmeyer R; Cousins MM; Mullis CE; Konikoff J; Donnell D; Celum C; Buchbinder SP; Seage GR; Kirk GD; Mehta SH; Astemborski J; Jacobson LP; Margolick JB; Brown J; Quinn TC; Eshleman SH
    J Infect Dis; 2013 Jan; 207(2):232-9. PubMed ID: 23129760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.
    Laeyendecker O; Kulich M; Donnell D; Komárek A; Omelka M; Mullis CE; Szekeres G; Piwowar-Manning E; Fiamma A; Gray RH; Lutalo T; Morrison CS; Salata RA; Chipato T; Celum C; Kahle EM; Taha TE; Kumwenda NI; Karim QA; Naranbhai V; Lingappa JR; Sweat MD; Coates T; Eshleman SH
    PLoS One; 2013; 8(11):e78818. PubMed ID: 24236054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.
    Laeyendecker O; Konikoff J; Morrison DE; Brookmeyer R; Wang J; Celum C; Morrison CS; Abdool Karim Q; Pettifor AE; Eshleman SH
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29489059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
    Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
    PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities.
    Xu Y; Laeyendecker O; Wang R
    Biometrics; 2019 Sep; 75(3):1017-1028. PubMed ID: 30746695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
    Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
    PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study.
    Eshleman SH; Hughes JP; Laeyendecker O; Wang J; Brookmeyer R; Johnson-Lewis L; Mullis CE; Hackett J; Vallari AS; Justman J; Hodder S
    J Infect Dis; 2013 Jan; 207(2):223-31. PubMed ID: 23129758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Sectional HIV Incidence Estimation with Missing Biomarkers.
    Morrison D; Laeyendecker O; Konikoff J; Brookmeyer R
    Stat Commun Infect Dis; 2018 Dec; 10(1):. PubMed ID: 30701015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing high-throughput HIV incidence assay with pyrosequencing platform.
    Park SY; Goeken N; Lee HJ; Bolan R; Dubé MP; Lee HY
    J Virol; 2014 Mar; 88(5):2977-90. PubMed ID: 24371062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A top scoring pairs classifier for recent HIV infections.
    Chen A; Laeyendecker O; Eshleman SH; Monaco DR; Kammers K; Larman HB; Ruczinski I
    Stat Med; 2021 May; 40(11):2604-2612. PubMed ID: 33660319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical power and estimation of incidence rate ratios obtained from BED incidence testing for evaluating HIV interventions among young people.
    Auvert B; Mahiane GS; Lissouba P; Moreau T
    PLoS One; 2011; 6(8):e21149. PubMed ID: 21853019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.